• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Performant Financial Corporation (Amendment)

    8/31/22 4:40:00 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary
    Get the next $PFMT alert in real time by email
    SC 13D/A 1 d402042dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*

     

     

    Performant Financial Corporation

    (Name of Issuer)

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

    71377E105

    (CUSIP Number)

    Mill Road Capital II, L.P.

    Attn: Thomas E. Lynch

    382 Greenwich Avenue

    Suite One

    Greenwich, CT 06830

    203-987-3500

    With a copy to:

    Peter M. Rosenblum, Esq.

    Foley Hoag LLP

    155 Seaport Blvd.

    Boston, MA 02210

    617-832-1151

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    August 26, 2022

    (Date of Event which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are sent.

     

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 71377E105    13D    Page 2 of 7 Pages

     

      1.   

    Names of Reporting Persons.

     

    Mill Road Capital II, L.P.

      2.  

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a)  ☐        (b)  ☐

     

      3.  

    SEC Use Only

     

      4.  

    Source of Funds (See Instructions)

     

    WC

      5.  

    Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

    ☐

      6.  

    Citizenship or Place of Organization

     

    Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

     

         7.    

    Sole Voting Power

     

    3,261,675

         8.   

    Shared Voting Power

     

         9.   

    Sole Dispositive Power

     

    3,261,675

       10.   

    Shared Dispositive Power

     

    11.   

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    3,261,675

    12.  

    Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

    ☐

    13.  

    Percent of Class Represented by Amount in Row (11)

     

    4.4%

    14.  

    Type of Reporting Person (See Instructions)

     

    PN


    CUSIP No. 71377E105    13D    Page 3 of 7 Pages

     

      1.   

    Names of Reporting Persons

     

    Mill Road Capital II GP LLC

      2.  

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a)  ☐        (b)  ☐

     

      3.  

    SEC Use Only

     

      4.  

    Source of Funds (See Instructions)

     

    AF

      5.  

    Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

    ☐

      6.  

    Citizenship or Place of Organization

     

    Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

     

         7.    

    Sole Voting Power

     

    3,261,675

         8.   

    Shared Voting Power

     

         9.   

    Sole Dispositive Power

     

    3,261,675

       10.   

    Shared Dispositive Power

     

    11.   

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    3,261,675

    12.  

    Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

    ☐

    13.  

    Percent of Class Represented by Amount in Row (11)

     

    4.4%

    14.  

    Type of Reporting Person (See Instructions)

     

    OO

     


    CUSIP No. 71377E105    13D    Page 4 of 7 Pages

     

      1.    

      Names of Reporting Persons.

     

      Thomas E. Lynch

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☐

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      AF

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      USA

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

         8.   

      Shared Voting Power

     

      3,261,675

         9.   

      Sole Dispositive Power

     

       10.   

      Shared Dispositive Power

     

      3,261,675

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      3,261,675

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      4.4%

    14.  

      Type of Reporting Person (See Instructions)

     

      IN

     


    CUSIP No. 71377E105    13D    Page 5 of 7 Pages

     

      1.    

      Names of Reporting Persons.

     

      Eric Yanagi

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☐

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      AF

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      USA

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      282,533

         8.   

      Shared Voting Power

     

         9.   

      Sole Dispositive Power

     

      282,533

       10.   

      Shared Dispositive Power

     

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      282,533

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      0.4%

    14.  

      Type of Reporting Person (See Instructions)

     

      IN

     

     


    CUSIP No. 71377E105       Page 6 of 7 Pages

     

    This Amendment No. 2 to the joint statement on Schedule 13D with respect to the common stock, par value $0.0001 per share (the “Common Stock”), of Performant Financial Corporation, a Delaware corporation (the “Issuer”), filed by the Reporting Persons (as defined below) on January 29, 2018, as amended by Amendment No. 1 on Schedule 13D with respect to the Common Stock filed by the Reporting Persons on May 12, 2020 (such joint statement, as amended herein, the “Schedule 13D”), amends the Schedule 13D as follows:

    1. Paragraphs (a), (b), (c) and (e) of Item 5 of the Schedule 13D shall hereby be amended and restated in full as follows:

     

      Item 5.

    Interest in Securities of the Issuer

    (a, b) The percentages of beneficial ownership reported in this Item 5, and on each Reporting Person’s cover page to this Schedule 13D, are based on a total of 73,818,124 shares of the Common Stock issued and outstanding as of August 8, 2022, as reported in most recent quarterly report of the Issuer on Form 10-Q for its fiscal quarter ended June 30, 2022. All of the share numbers reported below, and on each Reporting Person’s cover page to this Schedule 13D, are as of August 30, 2022, unless otherwise indicated. The cover page to this Schedule 13D for each Reporting Person is incorporated by reference in its entirety into this Item 5(a, b).

    Each of the Reporting Persons (other than Mr. Yanagi) beneficially owns 3,261,675 shares of Common Stock, or approximately 4.4% of the outstanding shares of Common Stock, and Mr. Yanagi beneficially owns 282,533 shares of Common Stock, or approximately 0.4% of the outstanding shares of Common Stock, and the Reporting Persons beneficially own, in the aggregate, 3,544,208 shares of Common Stock, or approximately 4.8% of the outstanding shares of Common Stock. Mr. Jacobs does not have beneficial ownership of any shares of Common Stock.

    (c) Except as otherwise described in this Schedule 13D, no Reporting Person effected any transaction in shares of the Common Stock since July 2, 2022 (the date 60 days prior to the filing of this Schedule 13D). On August 26, 2022, the Issuer granted 35,377 additional Director RSUs to Mr. Yanagi.

    (e) As of the date hereof, no Reporting Person is the beneficial owner of more than five percent of the outstanding shares of Common Stock.

    2. Except as expressly modified hereby, all provisions of the Schedule 13D shall continue in full force and effect.

    [signature pages follow]


    CUSIP No. 71377E105       Page 7 of 7 Pages

     

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    DATE:   August 31, 2022
    MILL ROAD CAPITAL II, L.P.
    By:   Mill Road Capital II GP LLC,
      its General Partner
    By:  

    /s/ Thomas E. Lynch

      Thomas E. Lynch
      Management Committee Director and Chairman
    MILL ROAD CAPITAL II GP LLC
    By:  

    /s/ Thomas E. Lynch

      Thomas E. Lynch
      Management Committee Director and Chairman
    THOMAS E. LYNCH

    /s/ Thomas E. Lynch

    Thomas E. Lynch
    ERIC YANAGI
    By:  

    /s/ Eric Yanagi

      Eric Yanagi
    Get the next $PFMT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PFMT

    DatePrice TargetRatingAnalyst
    7/25/2024$8.00Buy
    B. Riley Securities
    12/20/2022$8.00Buy
    Lake Street
    4/11/2022$8.00Buy
    Lake Street
    7/7/2021$10.00Buy
    Craig Hallum
    More analyst ratings

    $PFMT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Im Lisa sold $20,052 worth of shares (6,154 units at $3.26), decreasing direct ownership by 0.43% to 1,410,280 units (SEC Form 4)

    4 - Performant Healthcare Inc (0001550695) (Issuer)

    12/11/24 5:01:13 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer Kohl Simeon converted options into 61,788 shares and covered exercise/tax liability with 15,046 shares, increasing direct ownership by 12% to 424,824 units (SEC Form 4)

    4 - Performant Financial Corp (0001550695) (Issuer)

    8/15/24 8:25:15 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Chief Financial Officer Ramchandani Rohit converted options into 38,687 shares and covered exercise/tax liability with 13,805 shares, increasing direct ownership by 13% to 211,276 units (SEC Form 4)

    4 - Performant Financial Corp (0001550695) (Issuer)

    8/15/24 8:23:05 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    $PFMT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities initiated coverage on Performant Financial with a new price target

    B. Riley Securities initiated coverage of Performant Financial with a rating of Buy and set a new price target of $8.00

    7/25/24 8:25:58 AM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Lake Street resumed coverage on Performant Financial with a new price target

    Lake Street resumed coverage of Performant Financial with a rating of Buy and set a new price target of $8.00

    12/20/22 9:21:46 AM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Lake Street initiated coverage on Performant Financial with a new price target

    Lake Street initiated coverage of Performant Financial with a rating of Buy and set a new price target of $8.00

    4/11/22 9:19:13 AM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    $PFMT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Performant Healthcare, Inc. Ticker Symbol Change to "PHLT"

    Performant Healthcare, Inc. (NASDAQ:PFMT) ("Performant" or the "Company") is pleased to announce that its ticker symbol on the Nasdaq stock exchange will change from "PFMT" to "PHLT" effective as of market open on Wednesday, December 18, 2024. The change reflects Performant's strategic evolution into a pure-play healthcare payment integrity leader, underscoring its commitment to providing innovative solutions that reduce waste and abuse in the healthcare system. The transition to "PHLT" requires no action from shareholders. Performant's common shares will continue to be listed on Nasdaq with no changes to the CUSIP number, GICS, and NAICS codes associated with the Company's common stock

    12/16/24 4:00:00 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Performant Announces Name Change to Performant Healthcare, Inc. – Concludes Strategic Shift to Healthcare

    New Nasdaq Ticker Symbol Will Be PHLT Performant Financial Corporation (NASDAQ:PFMT) today announced it has changed its name to Performant Healthcare, Inc. ("Performant" or the "Company"), and plans to update its ticker symbol to PHLT. The name change and new ticker symbol will not impact the Company's operations, management or structure. Performant, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, is changing its name to reflect its strategic commitment to becoming a pure-play leader in healthcare payment integrity. "The name Performant Healthcare, Inc. reflects our commitment to delivering world-class payment integrity solution

    12/10/24 5:00:00 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Performant to Participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference

    Performant Financial Corporation (NASDAQ:PFMT) (the "Company"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that it will participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference, taking place in Boca Raton on Tuesday, December 3rd. Simeon Kohl, CEO, will present and meet with investors to discuss key updates, including the recent New York State Medicaid RAC award, progress on efficiency initiatives aimed at margin improvement, successful commercial implementations and a robust pipeline, and upcoming government opportunities. We're excited to share these developments as we continue dr

    11/26/24 4:05:00 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    $PFMT
    SEC Filings

    View All

    Performant Financial Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Performant Healthcare Inc (0001550695) (Filer)

    12/10/24 4:13:29 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    SEC Form 10-Q filed by Performant Financial Corporation

    10-Q - Performant Financial Corp (0001550695) (Filer)

    11/7/24 4:21:13 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Performant Financial Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Performant Financial Corp (0001550695) (Filer)

    11/6/24 4:12:31 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    $PFMT
    Leadership Updates

    Live Leadership Updates

    View All

    Performant Financial Corporation Announces the Appointment of Dr. Shantanu Agrawal to Its Board of Directors

    Performant Financial Corporation (NASDAQ:PFMT) (Performant), primarily operating as Performant Healthcare Solutions, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, is proud to announce the appointment of Dr. Shantanu Agrawal, M.D. to its Board of Directors. Dr. Agrawal brings a wealth of expertise and experience in healthcare policy and payment integrity. As Chief Health Officer at Elevance Health (NYSE:ELV), Dr. Agrawal oversees the whole health strategy, including medical policy and clinical quality, as well as the community health strategy and Elevance Health Foundation. Prior to Elevance Health, Dr. Agrawal held numerous execut

    3/6/24 4:30:00 PM ET
    $ELV
    $PFMT
    Medical Specialities
    Health Care
    Other Consumer Services
    Consumer Discretionary

    $PFMT
    Financials

    Live finance-specific insights

    View All

    Performant Financial Corporation Announces Financial Results for Third Quarter 2024

    Performant Financial Corporation (NASDAQ:PFMT), a leading provider of healthcare payment integrity services, today reported the following financial results for its third quarter ended September 30, 2024: Third Quarter Financial Highlights Healthcare revenues of $30.3 million, compared to $28.5 million in the prior year period, an increase of approximately 6%. Total revenues of $31.5 million, compared to total revenues of $30.0 million in the prior year period. Net loss of $2.4 million, or $(0.03) per diluted share, compared to net loss of $0.6 million, or $(0.01) per diluted share, in the prior year period. Adjusted EBITDA of $1.9 million, compared to $1.8 million in the prior year

    11/6/24 4:00:00 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Performant Financial Corporation to Report Third Quarter 2024 Earnings on November 6, 2024

    Performant Financial Corporation (NASDAQ:PFMT) (the Company), primarily operating under subsidiary Performant Healthcare Solutions, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that the company will report its third quarter 2024 results after the market closes Wednesday November 6, 2024. The Company will also hold a conference call to discuss results at 5:00 pm (Eastern Time) that day. To join the conference call: Dial in 800-717-1738 or 646-307-1865, or Live webcast through company's website here Replay can be found approximately three hours after the call on the company website under the Events & Presentations

    10/23/24 10:30:00 AM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Performant Financial Corporation Announces Financial Results for Second Quarter 2024

    Performant Financial Corporation (NASDAQ:PFMT), a leading provider of healthcare payment integrity services, today reported the following financial results for its second quarter ended June 30, 2024: Second Quarter Financial Highlights Healthcare revenues of $27.9 million, compared to $23.9 million in the prior year period, an increase of approximately 17%. Total revenues of $29.4 million, compared to total revenues of $25.5 million in the prior year period. Net loss of $3.0 million, or $(0.04) per diluted share, compared to net loss of $4.0 million, or $(0.05) per diluted share, in the prior year period. Adjusted EBITDA of $0.5 million, compared to $(1.3) million in the prior

    8/7/24 4:00:00 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    $PFMT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Performant Financial Corporation

    SC 13G/A - Performant Financial Corp (0001550695) (Subject)

    11/15/24 7:03:26 AM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Performant Financial Corporation

    SC 13G/A - Performant Financial Corp (0001550695) (Subject)

    11/14/24 4:41:31 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G filed by Performant Financial Corporation

    SC 13G - Performant Financial Corp (0001550695) (Subject)

    4/18/24 6:08:28 AM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary